Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily

PHASE3CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

March 31, 2007

Conditions
HIV Infections
Interventions
DRUG

efavirenz

Efavirenz

DRUG

Abacavir+lamivudine

Abacavir+lamivudine

Trial Locations (16)

18014

Hospital Virgen de las Nieves, Granada

20014

Hospital de Aranzazu, Donostia / San Sebastian

25198

Hospital Arnau de Vilanova de Lleida, Lleida

26001

Hospital San Millan de Logroño, Logroño

28005

Hospital Principe de Asturias, Alcalá de Henares

28911

Hospital Severo Ochoa Leganés, Madrid

28935

Hospital de Móstoles, Móstoles

29600

Hospital Costa del Sol, Marbella

31008

Hospital de Navarra, Pamplona

32005

Hospital Cristal-Piñor, Ourense

Hospital Santa María Nai, Ourense

38320

Hospital Universitario de Canarias, San Cristóbal de La Laguna

46014

Hospital General de Valencia, Valencia

08916

Germans Trias i Pujol Hospital, Badalona

08035

Hospital de la Vall d'Hebron, Barcelona

08304

Hospital de Mataró, Mataró

All Listed Sponsors
collaborator

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

OTHER

lead

Germans Trias i Pujol Hospital

OTHER

NCT00314626 - Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily | Biotech Hunter | Biotech Hunter